FABP4 mRNA expression level allowed identifying two subgroups both in NAFL and NASH patients based on their median relative gene expression levels (11.04 and 100.05, respectively; Fig. 4B). The gene discussed is FABP4; the disease is metabolic dysfunction-associated steatohepatitis.